RELATED CONTENT
NEWS
- EMILIA supports Roche's T-DM1 filing but MARIANNE will be key to market performance
- Roche's T-DM1 (Herceptin-plus) shows early benefit in first-line metastatic breast cancer
- CLEOPATRA - Roche's pertuzumab to queen it over HER2 breast cancer?
- New data set Herceptin on a subcutaneous, self-administration course
ANALYSIS
Other Informa Analysis
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

